Tag: CBT > DEA Scheduling: Page 5

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

South Carolina

Jamaica’s THC Exports to United States Leads CBT’s Most Popular Articles in February

Rescheduling, state legalization prospects, and Lume’s rapid rise in Michigan also ranked in Cannabis Business Times’ top 10 stories this month.

February 29, 2024

Regulations and Reform

DOJ Declines to Address Media Inquiry on Cannabis Rescheduling, Points to 2020 Resource Guide

A Department of Justice spokesperson said the government has nothing further to provide beyond its confirmation of review.

February 27, 2024

Cannabis Rescheduling

Former Police Chiefs, Prosecutors, Correctional Officials Urge Biden to Reschedule Cannabis

Officials who dedicated their careers to protecting public safety and reducing unnecessary arrests say cannabis prohibition has become problematic.

February 22, 2024

International

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

February 22, 2024

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024

Federal Cannabis Legalization

VP Kamala Harris Touts Changing ‘Federal Marijuana Policy’ in Campaign Video

Many industry stakeholders and advocates pushed back, saying the White House hasn’t changed anything since Biden took office.

February 12, 2024

Cannabis Rescheduling

Congressman Presses DEA For Answers on Ongoing Cannabis Scheduling Review

U.S. Rep. Earl Blumenauer wrote to DEA Administrator Anne Milgram Feb. 8 for further details on the review process, including when the agency might publish its draft rule on the scheduling of cannabis.

February 8, 2024

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024

Cannabis Retail Price

Rescheduling, Legalization Prospects Top CBT's Most-Read Articles in January

Here are Cannabis Business Times’ top 10 stories this month.

January 25, 2024

Cannabis Rescheduling

Colorado Attorney General Leads Multistate Effort to Support Cannabis Rescheduling

Attorney General Phil Weiser spearheaded a letter signed by 11 other state attorneys general to encourage the Drug Enforcement Administration to reclassify cannabis as a Schedule III drug under the Controlled Substances Act.

January 16, 2024